Daniel leads the development and implementation of strategic plans/partnerships associated with new product/partner offerings in Life Sciences (Pharma/Biotech/MD&D) at Microsoft. Previously, he was a founding member and the Director of Business Development and Strategy for Microsoft Genomics. In addition, he led a cross vertical (Payer, Provider, Health and Life Sciences, HHS) Microsoft Patient Engagement strategy with the goal of creating a strategic devices & services portfolio in health technology focusing on advancing the efficient access and delivery of healthcare. Prior to Microsoft, Daniel served as the Global Business Development Director for Phillips Healthcare.